Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after infection

During the COVID-19 pandemic, Portugal has experienced three distinct SARS-CoV-2 infection waves. We previously documented the prevalence of SARS-CoV-2 immunity, measured by specific antibodies, in September 2020, 6 months after the initial moderate wave. Here, we show the seroprevalence changes 6 months later, up to the second week of March 2021, shortly following the third wave, which was one of the most severe in the world, and 2 months following the start of the vaccination campaign. A longitudinal epidemiological study was conducted, with a stratified quota sample of the Portuguese population. Serological testing was performed, including ELISA determination of antibody class and titers. The proportion of seropositives, which was 2.2% in September 2020, rose sharply to 17.3% (95% CI: 15.8-18.8%) in March 2021. Importantly, circulating IgG and IgA antibody levels were very stable 6 months after the initial determination and up to a year after initial infection, indicating long-lasting infection immunity against SARS-CoV-2. Moreover, vaccinated people had higher IgG levels from 3 weeks post-vaccination when compared with previously infected people at the same time post-infection.

Automated summary

During the COVID-19 pandemic in Portugal, there were three waves of SARS-CoV-2 infection. The study found a significant increase in seroprevalence of SARS-CoV-2 antibodies in the Portuguese population from September 2020 to March 2021, indicating long-lasting infection immunity. Additionally, vaccinated individuals had higher levels of antibodies compared to those previously infected after 3 weeks post-vaccination.